Janet S. Macpherson

1.0k total citations
30 papers, 861 citations indexed

About

Janet S. Macpherson is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Janet S. Macpherson has authored 30 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Janet S. Macpherson's work include Cancer therapeutics and mechanisms (12 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Janet S. Macpherson is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Janet S. Macpherson collaborates with scholars based in United Kingdom, United States and Australia. Janet S. Macpherson's co-authors include John F. Smyth, Duncan I. Jodrell, John E. T. Corrie, Jeffrey L. Cummings, Richard L. Hayward, W A Ratcliffe, C. Roland Wolf, Jeff Cummings, Brett P. Monia and W. M. Hunter and has published in prestigious journals such as Analytical Biochemistry, The American Journal of Human Genetics and Journal of neurosurgery.

In The Last Decade

Janet S. Macpherson

30 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet S. Macpherson United Kingdom 16 385 333 119 115 98 30 861
Edward A. Barker United States 18 911 2.4× 274 0.8× 83 0.7× 89 0.8× 87 0.9× 25 1.4k
Lee R. Tanzer United States 14 473 1.2× 464 1.4× 96 0.8× 67 0.6× 54 0.6× 21 856
Marek Mirowski Poland 18 459 1.2× 549 1.6× 96 0.8× 62 0.5× 150 1.5× 106 1.1k
Bruce Dickstein United States 14 327 0.8× 573 1.7× 79 0.7× 122 1.1× 76 0.8× 20 949
John A. Kellen Canada 14 344 0.9× 318 1.0× 67 0.6× 74 0.6× 72 0.7× 61 919
O. Michael Colvin United States 15 337 0.9× 197 0.6× 98 0.8× 37 0.3× 32 0.3× 23 790
Lela Buckingham United States 17 505 1.3× 353 1.1× 71 0.6× 53 0.5× 73 0.7× 48 983
Barbara A. Domin United States 20 501 1.3× 201 0.6× 88 0.7× 87 0.8× 33 0.3× 31 1.1k
W R Laster United States 17 397 1.0× 317 1.0× 175 1.5× 47 0.4× 48 0.5× 42 957
Michèle Masquelier Sweden 17 427 1.1× 218 0.7× 103 0.9× 33 0.3× 161 1.6× 34 962

Countries citing papers authored by Janet S. Macpherson

Since Specialization
Citations

This map shows the geographic impact of Janet S. Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet S. Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet S. Macpherson more than expected).

Fields of papers citing papers by Janet S. Macpherson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet S. Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet S. Macpherson. The network helps show where Janet S. Macpherson may publish in the future.

Co-authorship network of co-authors of Janet S. Macpherson

This figure shows the co-authorship network connecting the top 25 collaborators of Janet S. Macpherson. A scholar is included among the top collaborators of Janet S. Macpherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet S. Macpherson. Janet S. Macpherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guichard, Sylvie M., Janet S. Macpherson, Morwenna Muir, et al.. (2008). Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. European Journal of Cancer. 44(2). 310–317. 14 indexed citations
2.
Guichard, Sylvie M., et al.. (2007). Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model. Cancer Chemotherapy and Pharmacology. 60(5). 651–660. 7 indexed citations
3.
Aird, Rhona, Marian Thomson, Janet S. Macpherson, et al.. (2007). ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136. The Pharmacogenomics Journal. 8(4). 289–296. 6 indexed citations
4.
Hayward, Richard L., Janet S. Macpherson, Rhona Aird, et al.. (2005). Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175. Cancer Chemotherapy and Pharmacology. 55(6). 577–583. 68 indexed citations
5.
Macpherson, Janet S., Duncan I. Jodrell, & Sylvie M. Guichard. (2005). Validation of real-time reverse-transcription-polymerase chain reaction for quantification of capecitabine-metabolizing enzymes. Analytical Biochemistry. 350(1). 71–80. 5 indexed citations
6.
Guichard, Sylvie M., Janet S. Macpherson, David E. Thurston, & Duncan I. Jodrell. (2005). Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136. European Journal of Cancer. 41(12). 1811–1818. 15 indexed citations
7.
Mirza, Muddassar M., Sheila Fisher, Kathy King, et al.. (2003). Genetic Evidence for Interaction of the 5q31 Cytokine Locus and the CARD15 Gene in Crohn Disease. The American Journal of Human Genetics. 72(4). 1018–1022. 82 indexed citations
8.
Cummings, Jeffrey L., Brian Ethell, Lesley Jardine, et al.. (2003). Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives.. PubMed. 63(23). 8443–50. 70 indexed citations
9.
Hayward, Richard L., Janet S. Macpherson, Jeff Cummings, et al.. (2003). Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.. PubMed. 9(7). 2856–65. 56 indexed citations
10.
Cummings, Jeffrey L., Gary W. Boyd, Brian Ethell, et al.. (2002). Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation. Biochemical Pharmacology. 63(4). 607–613. 48 indexed citations
11.
Macpherson, Janet S., et al.. (1997). Cell cycle effects of the novel topoisomerase I inhibitor NU/ICRF 505 in a panel of chinese hamster ovary cell lines. European Journal of Cancer. 33(2). 280–283. 5 indexed citations
12.
Cummings, Jeffrey L., et al.. (1996). Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 685(1). 159–164. 5 indexed citations
13.
14.
Cummings, Jeffrey L., et al.. (1995). Biochemistry of topoisomerase I and II inhibition by anthracenyl-amino acid conjugates. Biochemical Pharmacology. 49(12). 1747–1757. 18 indexed citations
15.
Cummings, Jeffrey L., et al.. (1995). Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU / ICRF 500. Mutation Research/Genetic Toxicology. 344(1-2). 55–62. 14 indexed citations
16.
Macpherson, Janet S., et al.. (1990). A PHARMACOKINETIC STUDY OF HIGH-DOSE METOCLOPRAMIDE SUPPOSITORIES. Journal of Clinical Pharmacy and Therapeutics. 15(1). 21–24. 3 indexed citations
17.
Whittle, Ian R., Janet S. Macpherson, J. Douglas Miller, & John F. Smyth. (1990). The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications. Journal of neurosurgery. 72(5). 721–725. 11 indexed citations
18.
Gunnarsson, P. O., Jette Vibe-Petersen, Janet S. Macpherson, et al.. (1989). Pharmacokinetics of tauromustine in cancer patients. Cancer Chemotherapy and Pharmacology. 23(3). 176–80. 10 indexed citations
19.
Smyth, John F., et al.. (1987). Phase I study of TCNU, a novel nitrosourea. European Journal of Cancer and Clinical Oncology. 23(12). 1845–1849. 18 indexed citations
20.
Macpherson, Janet S., et al.. (1986). The clinical pharmacology of mitozantrone. Cancer Chemotherapy and Pharmacology. 17(2). 149–152. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward A. Barker Breakdown of academic impact, for papers by Lee R. Tanzer Breakdown of academic impact, for papers by Marek Mirowski Breakdown of academic impact, for papers by Bruce Dickstein Breakdown of academic impact, for papers by John A. Kellen Breakdown of academic impact, for papers by O. Michael Colvin Breakdown of academic impact, for papers by Lela Buckingham Breakdown of academic impact, for papers by Barbara A. Domin Breakdown of academic impact, for papers by W R Laster Breakdown of academic impact, for papers by Michèle Masquelier
Rankless by CCL
2026